checkAd

     562  0 Kommentare Horizon Pharma plc Provides Update on Shareholders Meeting Related to the Proposed Acquisition of Depomed, Inc. - Seite 4

    Contacts:
    Investors:
    John Thomas
    Executive Vice President, Strategy and Investor Relations
    investor-relations@horizonpharma.com

    Tina Ventura
    Vice President, Investor Relations
    investor-relations@horizonpharma.com

    Dan Burch
    MacKenzie Partners, Inc.
    212-929-5748
    dburch@mackenziepartners.com

    Bob Marese
    MacKenzie Partners, Inc.
    212-929-5405
    bmarese@mackenziepartners.com

    U.S. Media:
    Geoff Curtis
    Group Vice President, Corporate Communications
    media@horizonpharma.com

    Daniel Yunger
    Kekst
    daniel-yunger@kekst.com

    Ireland Media:
    Ray Gordon
    Gordon MRM
    ray@gordonmrm.ie

    Lesen Sie auch

    Diskutieren Sie über die enthaltenen Werte


    Seite 4 von 4

    Verfasst von Marketwired
    6 im Artikel enthaltene WerteIm Artikel enthaltene Werte
    Horizon Pharma plc Provides Update on Shareholders Meeting Related to the Proposed Acquisition of Depomed, Inc. - Seite 4 DUBLIN, IRELAND--(Marketwired - Nov 13, 2015) - Horizon Pharma plc (NASDAQ: HZNP) ("Horizon Pharma"), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and …